Stratagene—an Agilent Technologies Division—is a pioneer in mutagenesis tools for targeted protein engineering. Through an innovative portfolio of site-directed and random mutagenesis kits, we help researchers investigate—and publish on—protein structure and function. For over two decades, we have been developing mutagenesis tools that deliver results you can count on.
More mutations, more quickly
QuikChange site-directed mutagenesis kits enable multiple point mutations to be introduced simultaneously without subcloning, so mutants are ready to be sequenced in one day, with superior yields and high mutation efficiencies. For faster results, use QuikChange Lightening, and finish your experiment in three hours.
Our GeneMorph random mutagenesis kits utilize the Mutazyme II polymerase, specifically engineered to deliver a balanced mutational spectrum, while our simple protocol delivers full control over mutation frequency.